Word: drugging
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Drugs already get a lot of government scrutiny—too much, in fact. A 2001 study by the Tufts Center for the Study of Drug Development showed that once drug development was initiated, it took an average of $802 million and 10 to 15 years for a drug company to win the right to offer their product to American consumers. During those years, every American that could have benefited from the drug—either by having a higher quality of life, or by being alive at all—has not, while her cohorts in less draconian countries...
...indeed, that is what many of the more careful news reports recommend. The report that found the 10 cases of heart problems noted at the same time that Gleevec is a “wonderful drug and patients with these diseases need to be on it.” But, in general, recent coverage of the adverse side effects of certain drugs tends to generate calls for more stringent—and thus longer and more expensive—FDA screening...
Further, the tremendous sum that it costs to get a drug approved severely constrains the number of drugs companies are willing to develop. If a pharmaceutical company cannot expect to make back their costs—which could reach over $1 billion—in sales from a drug, it will not even go to the trouble of submitting the drug for FDA approval. This limits the options available to those with rare diseases, because the FDA creates a huge disincentive to make drugs that will only help a “niche” market. That explains...
This is very bad news for patients with terminal illnesses. Certain that they are going to die if a treatment for their disease is not made available quickly, terminally ill patients are generally quite willing to try anything that might work, even if the drug is risky. When patients have little to lose, it seems completely unreasonable for the FDA to not even let them try. That may be why the federal appeals court for the D.C. Circuit, the court that hears cases about regulatory agencies, ruled on May 2 that “a terminally ill, mentally competent adult...
...will give a clue as to how badly the G.O.P. thinks it needs to reform itself. Boehner took over his post only in February after replacing the scandal-plagued former Majority Whip, Tom DeLay. So much of the spending many House conservatives hated, such as the 2003 Medicare prescription drug bill that President Bush pushed them to approve, happened before Boehner was in the leadership. And Boehner is famous for having never asked for any wasteful pork-barrel projects for his own district, a stance many fiscal conservatives like. Missouri congressman Roy Blunt, who will face Shadegg in the race...